QR-Code

Sustained on/off-treatment disease control with abrocitinib for moderate-to-severe atopic dermatitis

Purpose Achieving sustained on- and off-treatment disease control is an important therapeutic goal in atopic dermatitis (AD). This study evaluated achievement of off-treatment disease control in patients randomized to placebo following 12 weeks of abrocitinib 200 mg.Materials and methods In the phas...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Emma Guttman-Yassky, Thomas Bieber, Kenji Kabashima, Jan Gutermuth, Stephan Weidinger, Andreas Wollenberg, Irina Lazariciu, Gerardo Encinas, Marina Mikheil, Melissa Watkins
Format: Artigo
Sprache:Inglês
Veröffentlicht: Taylor & Francis Group 2026-12-01
Schriftenreihe:Journal of Dermatological Treatment
Schlagworte:
Abrocitinib
atopic dermatitis
disease control
flare
off-treatment
remission
Online-Zugang:https://www.tandfonline.com/doi/10.1080/09546634.2026.2672328
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge